Literature DB >> 2335049

Hyperuricemia-hyperlipemia association in the absence of obesity and alcohol abuse.

E Collantes Estevez1, M Pineda Priego, J Añon Barbudo, P Sanchez Guijo.   

Abstract

We carried out a study of 43 male asymptomatic subjects with high levels of uric acid but showing no signs of arterial hypertension, obesity or alcohol abuse. Initially, we investigated cholesterol levels, triglycerides in blood serum and the very low density lipoprotein fraction. The results showed asymptomatic hyperuricemia, frequently associated with mixed hyperlipidemia or hypertriglyceridemia. In our cases, however, the association was not connected to exogenous factors such as obesity or alcohol consumption. We also found the very low density lipoprotein fraction to be anomalous compared to the control group, which suggests that the metabolism of this lipoprotein is altered by the aforesaid association.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2335049     DOI: 10.1007/bf02030237

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

1.  Gout and its relation to lipid metabolism. I. Serum uric acid, lipid, and lipoprotein levels in gout.

Authors:  H Mielants; E M Veys; A de Weerdt
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

2.  [Gout and hyperlipidemias (study on 50 gouty patients and 50 non gouty patients)].

Authors:  J Rondier; J Truffert; A Le Go; H Brouilhet; L Saporta; J L de Gennes; F Delbarre
Journal:  Rev Eur Etud Clin Biol       Date:  1970-11

3.  Long-term effects of cigarette smoking and moderate alcohol consumption on coronary artery diameter. Mechanisms of coronary artery disease independent of atherosclerosis or thrombosis?

Authors:  L P Fried; R D Moore; T A Pearson
Journal:  Am J Med       Date:  1986-01       Impact factor: 4.965

4.  [Blood uric acid and coronary disease. Direct role or statistical relation to lipid disorders].

Authors:  R Bartolin; G Bouvenot; C Delboy; G Soula; S Levy
Journal:  Arch Mal Coeur Vaiss       Date:  1981-11

5.  Serum uric acid and coronary heart disease.

Authors:  J T Beard
Journal:  Am Heart J       Date:  1983-08       Impact factor: 4.749

Review 6.  Pathogenesis of hyperlipoproteinemia.

Authors:  S M Grundy
Journal:  J Lipid Res       Date:  1984-12-15       Impact factor: 5.922

7.  [HDL-cholesterol in patients with gout (author's transl)].

Authors:  H Yamanaka; T Watanabe; T Kawai; K Nishioka; I Sakurabayashi; K Mikanagi
Journal:  Ryumachi       Date:  1981-03

8.  High uric acid as an indicator of cardiovascular disease. Independence from obesity.

Authors:  W J Fessel
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

9.  Serum lipids and lipoproteins in patients with primary gout.

Authors:  A Ulreich; G M Kostner; K P Pfeiffer; P Sedlmayr; F Rainer
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

10.  Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.

Authors:  J D Brunzell; J J Albers; A Chait; S M Grundy; E Groszek; G B McDonald
Journal:  J Lipid Res       Date:  1983-02       Impact factor: 5.922

View more
  9 in total

1.  Hyperlipidaemia in hyperuricaemia and gout.

Authors:  B Emmerson
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

2.  Decreased triglyceride levels with low calorie diet and increased renal excretion of uric acid in hyperuricaemic-hyperlipidaemic patients.

Authors:  F J Tinahones; F J Soriguer; E Collantes; G Pérez-Lindón; P Sánchez Guijo; J A Lillo
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

3.  Renal excretion of urate by hyperuricaemic-hyperlipidemic patients.

Authors:  E Collantes Estevéz; F J Tinahones Madueño; A González Ruiz; J Añón Barbudo; M Pineda Priego; P Sánchez Guijo
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

4.  Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation.

Authors:  Chuang Wang; Ying Pan; Qing-Yu Zhang; Fu-Meng Wang; Ling-Dong Kong
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

5.  Epidemiology of obesity in elderly people.

Authors:  C C Lin; T C Li; S W Lai; C I Li; K C Wanga; C K Tan; K C Ng; C S Liu
Journal:  Yale J Biol Med       Date:  1999 Nov-Dec

6.  Hypercholesterolemia and its correlates in Taiwanese elderly people.

Authors:  C C Lin; T C Li; S W Lai; C I Li; C K Tan; K C Ng; M M Lai; C S Liu
Journal:  Yale J Biol Med       Date:  1999 Nov-Dec

7.  Effect of fenofibrate in combination with urate lowering agents in patients with gout.

Authors:  You-Hyun Lee; Chan-Hee Lee; Jisoo Lee
Journal:  Korean J Intern Med       Date:  2006-06       Impact factor: 2.884

8.  The association between hyperuricemia and betel nut chewing in Taiwanese men: a cross-sectional study.

Authors:  Tsai-Sung Tai; Chih-Cheng Hsu; Hsiang-Chu Pai; Wen-Hsin Liu; Yueh-Han Hsu
Journal:  BMC Public Health       Date:  2013-12-05       Impact factor: 3.295

9.  Association of plasma free amino acids with hyperuricemia in relation to diabetes mellitus, dyslipidemia, hypertension and metabolic syndrome.

Authors:  M H Mahbub; Natsu Yamaguchi; Hidekazu Takahashi; Ryosuke Hase; Yasutaka Ishimaru; Hiroshi Sunagawa; Hiroki Amano; Mikiko Kobayashi-Miura; Hideyuki Kanda; Yasuyuki Fujita; Hiroshi Yamamoto; Mai Yamamoto; Shinya Kikuchi; Atsuko Ikeda; Naoko Kageyama; Mina Nakamura; Tsuyoshi Tanabe
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.